| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 12/20/2007 | US20070293520 2,4-pyrimidinediamine compounds and their uses |
| 12/20/2007 | US20070293496 Nitrogen containing heterocyclic compounds and medicines containing the same |
| 12/20/2007 | US20070293474 Combination of a DPP IV inhibitor and a cardiovascular compound |
| 12/20/2007 | US20070293454 Complex Containing Mequitazine, a Cyclodextrin and an Interaction Agent |
| 12/20/2007 | US20070293431 Method for improving neurotransmission failure using a novel agent |
| 12/20/2007 | US20070292496 Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics |
| 12/20/2007 | US20070292476 Delivery of ophthalmologic agents to the exterior or interior of the eye |
| 12/20/2007 | US20070292475 Controlled release microparticles |
| 12/20/2007 | US20070292474 A scaffold of biodegradable biopolymers including a combination of either collagen or gelatin and either chondroitin-6-sulfate, chondrotin-4-sulfate, heparin, heparan sulfate, keratan sulfate, dermatan sulfate, chitin, or chitosan; tissue engineering; glaucoma; antiscarring agents; kits; druug-free |
| 12/20/2007 | US20070292355 Alcohol-free drug or cosmetics carrier mixture of water, hydrophobic solvent, surfactant and gelling agent; oil in water emulsions |
| 12/19/2007 | EP1867334A1 Method of relieving or avoiding side effect of steroid compound |
| 12/19/2007 | EP1865949A2 Modulators of atp-binding cassette transporters |
| 12/19/2007 | EP1865948A1 Vitamin mixtures |
| 12/19/2007 | EP1865943A1 Use of acetyl-leucine for preparing a drug for treating balance disorders |
| 12/19/2007 | EP1503757B1 Tyrosine kinase inhibitors |
| 12/19/2007 | EP1497261B1 Phenethanolamine derivatives |
| 12/19/2007 | EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/19/2007 | EP1470122B1 Rho-kinase inhibitors |
| 12/19/2007 | EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 12/19/2007 | EP1370521B1 Formanilide derivatives as beta2-adrenoreceptor agonists |
| 12/19/2007 | EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity |
| 12/19/2007 | EP1292596B1 1,3,8-triaza-spiro¬4,5 decan-4-one derivatives as neurokinin receptor antagonists |
| 12/19/2007 | CN101090707A Medicament for hygienic application inside the ear |
| 12/19/2007 | CN100355753C Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds |
| 12/19/2007 | CN100355731C Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof |
| 12/19/2007 | CN100355455C Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use |
| 12/19/2007 | CN100355430C Tibetan medicine for treating eye diseases, and its preparing method |
| 12/18/2007 | US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 12/18/2007 | US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
| 12/18/2007 | US7309689 Sustained peptide-release formulation |
| 12/18/2007 | CA2233042C Specific binding members for human transforming growth factor beta; materials and methods |
| 12/13/2007 | WO2007142323A1 Novel indazole derivative having spiro ring structure in side chain |
| 12/13/2007 | WO2007142096A1 Inhibitor of inducible nitric oxide synthase, beverage/food, and neutraceutical food |
| 12/13/2007 | WO2007141898A1 Ameliorant for eye strain |
| 12/13/2007 | WO2007141764A1 Use of at least one polyphenol for promoting eye health |
| 12/13/2007 | WO2007141533A2 Fkbp-l and uses thereof |
| 12/13/2007 | WO2007105171A3 Killing of selected cells |
| 12/13/2007 | WO2006119128A3 Vascular targeting of ocular neovascularization |
| 12/13/2007 | US20070287756 Methods and Compositions for Preserving the Viability of Photoreceptor Cells |
| 12/13/2007 | US20070287749 Bromfenac ophthalmic formulations and methods of use |
| 12/13/2007 | US20070287721 Pyrazolopyridinyl pyridine |
| 12/13/2007 | US20070287706 Certain substituted quinolones, compositions, and uses thereof |
| 12/13/2007 | US20070287670 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 12/13/2007 | US20070287662 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 12/13/2007 | US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 12/13/2007 | CA2657947A1 Fkbp-l and uses thereof |
| 12/13/2007 | CA2654303A1 Use of at least one polyphenol for promoting eye health |
| 12/13/2007 | CA2653424A1 Novel indazole derivative having spiro ring structure in side chain |
| 12/12/2007 | EP1864994A1 Par-2 agonist |
| 12/12/2007 | EP1864975A2 Novel compounds |
| 12/12/2007 | EP1864678A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the PEDF gene |
| 12/12/2007 | EP1864668A1 Use of prodrugs for ocular intravitreous administration |
| 12/12/2007 | EP1864667A1 Use of prodrugs for ocular intravitreous administration |
| 12/12/2007 | EP1864666A1 Protective agent for retinal neuronal cell containing prostaglandin f2 alpha derivative as active ingredient |
| 12/12/2007 | EP1864664A1 Pharmaceutical preparation |
| 12/12/2007 | EP1863802A1 Substituted piperidines as renin inhibitors |
| 12/12/2007 | EP1863763A1 3,4,5-substituted piperidines as renin inhibitors |
| 12/12/2007 | EP1863467A2 Combination of organic compounds |
| 12/12/2007 | EP1309618B1 Leucine-based motif and clostridial neurotoxins |
| 12/12/2007 | EP1276738B1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 12/12/2007 | EP1268481B1 Kinase inhibitors as therapeutic agents |
| 12/12/2007 | EP1180119B1 Recombinant haemophilus influenzae adhesin proteins |
| 12/12/2007 | EP1000144B1 Lactoferrin receptor gene of moraxella |
| 12/12/2007 | CN101087613A Preventing or treating agent for glaucoma |
| 12/12/2007 | CN101085238A Traditional Chinese medicine formula for treating intraocular hemorrhage |
| 12/12/2007 | CN101085174A Traditional Chinese medicine oral liquid with kidney-nourishing eyesight-improving and health-care function |
| 12/12/2007 | CN101085120A Beverage containing polygala root and acorus calamus |
| 12/12/2007 | CN101085112A Medlar and rehmanniae radix wine |
| 12/12/2007 | CN101084916A Application of hyaluronate in preparing oral products used for preventing or improving ocular vitreous degeneration disease |
| 12/12/2007 | CN100354291C Novel natural drug effective region |
| 12/12/2007 | CN100354277C 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 12/12/2007 | CN100353972C Chinese and western medicine combined medicine and food dual purpose product for preventing and treating cornea malacia and its manufacturing method |
| 12/12/2007 | CN100353950C Medicine Rb2 used for thrombolysis, anti reperfusion injury, improving microcirculation and repairing injured tissue and its prepn. method |
| 12/12/2007 | CN100353947C Remedies for retina and choroid diseases containing steroids as the active ingredient |
| 12/12/2007 | CN100353942C Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 12/11/2007 | US7307164 β-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/11/2007 | US7307102 Administering selective estrogen receptor modulators that possesses tissue-specific ER agonist activity |
| 12/11/2007 | US7307096 For intraocular pressure lowering action; for therapy and prophylaxis |
| 12/11/2007 | US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 12/11/2007 | US7307080 Nuclear enzyme poly(adenosine 5'-diphospho-ribose) polymerase inhibitors; protection against ill effects of reactive free radicals and nitric oxide |
| 12/11/2007 | US7307075 Tetrahydroquinoline analogues as muscarinic agonists |
| 12/11/2007 | CA2405822C Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof |
| 12/11/2007 | CA2348735C Heterocyclic potassium channel inhibitors |
| 12/11/2007 | CA2184077C Nasal and ocular administration of ketamine to manage pain and for detoxification |
| 12/06/2007 | WO2007140197A1 Therapeutic pyrrolidine compounds |
| 12/06/2007 | WO2007139240A1 7-(3,4-dialkoxyphenyl)-pyrazolo[1,5-a]pyrimidine compounds, process for preparing thereof, and pharmaceutical composition for treating or preventing asthma, chronic obstructive pulmonary disease, arthritis, atopic dermatitis, tumor and degenerative brain diseases comprising the same |
| 12/06/2007 | WO2007139230A1 Seven-membered ring compound, production method thereof and pharmaceutical use thereof |
| 12/06/2007 | WO2007138993A1 Method for culture of lactic acid bacterium having high immunomodulating activity |
| 12/06/2007 | WO2007138114A1 Use of prodrugs for ocular intravireous administration |
| 12/06/2007 | WO2007138113A1 Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye |
| 12/06/2007 | WO2007137369A1 Medicinal compositions containing honey |
| 12/06/2007 | WO2007067519A3 The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions |
| 12/06/2007 | US20070282012 Reagent for Lacrimation Examination and Method of Lacrimation Examination |
| 12/06/2007 | US20070281988 Combination Therapy for Vascular Complications Associated with Hyperglycemia |
| 12/06/2007 | US20070281952 Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists |
| 12/06/2007 | US20070281936 To reducte the purinergic neurotransmission; Parkinson's disease; dyskinesias; Movement disorders; Adenosine receptors antagonists; 2-Methylamino-6-(5-methyl-2-furyl)-N-(2-pyridylmethyl)pyrimidine-4-carboxamide |
| 12/06/2007 | US20070281919 Aminothiazole Derivatives And Their Use As CRF Receptor Ligands |
| 12/06/2007 | US20070281913 Method for treating eye disease or conditions affecting the posterior segment of the eye |
| 12/06/2007 | US20070280995 Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye |
| 12/06/2007 | US20070280964 Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis |